Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...

Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...

Hedge fund Starboard Value's latest activist campaign targeting Pfizer (NYSE:PFE) has boosted the company's shares in recent ...

Plus: US jobless claims surge amid Helene hit; Nicholas Moore pushes Hanoi, not London as startup hub; HSBC to cull senior ...

Pfizer Inc.'s stock dipped 2.5% Thursday as the company's battle with activist shareholder Starboard Value heated up, after two former executives for the pharma giant said they would not support ...

Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for ...